Diltiazem HCl Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.

Veterinarians most commonly consider diltiazem for patients presented with heart disease, particularly hypertrophic cardiomyopathy (HCM) in feline patients. It is also frequently discussed in the context of supraventricular tachyarrhythmias, where managing a rapid or irregular heart rate is a primary clinical objective. The decision to select diltiazem is typically based on diagnostic findings from an echocardiogram or electrocardiogram (ECG) to confirm the structural and electrical status of the heart.

At a pharmacological level, diltiazem acts by inhibiting the influx of calcium ions through L-type voltage-gated channels in cardiac and vascular smooth muscle. This mechanism manages the depolarization process, which relaxes coronary and systemic blood vessels and slows electrical conduction through the atrioventricular (AV) node. By managing these physiological pathways, the medication provides a method for reducing the heart’s workload, managing blood pressure and supporting the heart’s ability to relax and fill with blood (diastolic function). Diltiazem is characterized by its relative selectivity for the myocardium and conduction system. Your veterinarian will determine the clinical appropriateness of diltiazem based on your pet’s specific cardiac profile, diagnostic results and health status.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects following the administration of diltiazem include localized digestive changes such as vomiting or a temporary decrease in appetite. Some animals may exhibit behavioral shifts including lethargy, weakness or a noticeable decrease in energy. Because diltiazem influence heart rhythm and vascular tone, your veterinarian will monitor for observational signs of a slow heart rate (bradycardia) or low blood pressure (hypotension). Owners should monitor their pet for any unusual fainting episodes, significant coordination changes or persistent changes in activity levels and contact their veterinarian promptly with any concerns.

This medication is typically used with extra caution or avoided in patients with known severe renal or hepatic impairment, as well as those presented with specific types of heart block or congestive heart failure. It is also carefully evaluated in pets with pre-existing low blood pressure. Significant interactions can occur if diltiazem is administered concurrently with other heart medications, specific diuretics, beta-blockers or certain immunosuppressants like cyclosporine. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most appropriate monitoring schedule—which may include periodic blood pressure checks and repeat ECGs—to ensure the management approach remains suitable for your pet's cardiac health.